Login / Signup

Toll/interleukin-1 receptor (TIR) domain-containing proteins have NAD-RNA decapping activity.

Xufeng WangDongli YuJiancheng YuHao HuRunlai HangZachary AmadorQi ChenJijie ChaiXuemei Chen
Published in: Nature communications (2024)
The occurrence of NAD + as a non-canonical RNA cap has been demonstrated in diverse organisms. TIR domain-containing proteins present in all kingdoms of life act in defense responses and can have NADase activity that hydrolyzes NAD + . Here, we show that TIR domain-containing proteins from several bacterial and one archaeal species can remove the NAM moiety from NAD-capped RNAs (NAD-RNAs). We demonstrate that the deNAMing activity of AbTir (from Acinetobacter baumannii) on NAD-RNA specifically produces a cyclic ADPR-RNA, which can be further decapped in vitro by known decapping enzymes. Heterologous expression of the wild-type but not a catalytic mutant AbTir in E. coli suppressed cell propagation and reduced the levels of NAD-RNAs from a subset of genes before cellular NAD + levels are impacted. Collectively, the in vitro and in vivo analyses demonstrate that TIR domain-containing proteins can function as a deNAMing enzyme of NAD-RNAs, raising the possibility of TIR domain proteins acting in gene expression regulation.
Keyphrases
  • gene expression
  • acinetobacter baumannii
  • pseudomonas aeruginosa
  • drug resistant
  • stem cells
  • dna methylation
  • nucleic acid
  • single cell
  • cystic fibrosis
  • genome wide identification